Publication | Closed Access
Nuclear–Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis
36
Citations
47
References
2018
Year
Our data implicate NCT as a potential therapeutic target in myelofibrosis and provide a rationale for clinical evaluation in ruxolitinib-exposed patients with myelofibrosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1